Sfoglia per Rivista RADIOTHERAPY AND ONCOLOGY
Impact of 4DCT target definition on 3DCRT and IMRT planning of locally advanced pancreatic carcinoma
2007-01-01 Sangalli, G; Passoni, P; Cattaneo, Gm; Broggi, S; Esposito, D; Bettinardi, V; Reni, M; Danna, M; Mancosu, P; Fazio, F; Calandrino, R
IMRT significantly reduces acute toxicity of whole-pelvis irradiation in patients treated with post-operative adjuvant or salvage radiotherapy after radical prostatectomy
2009-01-01 Alongi, F; Fiorino, C; Cozzarini, C; Broggi, S; Perna, L; Cattaneo, Gm; Calandrino, R; Di Muzio, N
In reply to Fiorino et al.: The central role of the radiation oncologist in the multidisciplinary & multiprofessional model of modern radiation therapy
2021-01-01 Alongi, F.; Arcangeli, S.; Cuccia, F.; D'Angelillo, R. M.; Di Muzio, N. G.; Filippi, A. R.; Jereczek-Fossa, B. A.; Livi, L.; Pergolizzi, S.; Scorsetti, M.; Corvo, R.; Magrini, S. M.
In-gantry or remote patient positioning? Monte Carlo simulations for proton therapy centers of different sizes
2012-01-01 Fava, G; Widesott, L; Fellin, F; Amichetti, M; Viesi, V; Lomax, Aj; Lederer, L; Hug, Eb; Fiorino, C; Salvadori, G; Di Muzio, N; Schwarz, M
Internal target volume defined by contrast-enhanced 4D-CT scan in unresectable pancreatic tumour: evaluation and reproducibility
2010-01-01 Cattaneo, Gm; Passoni, P; Sangalli, G; Slim, N; Longobardi, B; Mancosu, P; Bettinardi, V; Di Muzio, N; Calandrino, R
Intra- and inter-observer variability in contouring prostate and seminal vesicles: implications for conformal treatment planning
1998-01-01 Fiorino, C; Reni, M; Bolognesi, A; Cattaneo, Gm; Calandrino, R
Intra-operative radiotherapy (IORT) in pancreatic cancer: Joint analysis of the ISIORT-Europe experience
2009-01-01 Valentini, V; Calvo, F; Reni, M; Krempien, R; Sedlmayer, F; Buchler, Mw; Di Carlo, V; Doglietto, Gb; Fastner, G; Garcia-Sabrido, Jl; Mattiucci, G; Morganti, Ag; Passoni, P; Roeder, F; D'Agostino, Gr
Modeling set-up error by daily MVCT for prostate adjuvant treatment delivered in 20 fractions: Implications for the assessment of the optimal correction strategies
2009-01-01 Broggi, S; Cozzarini, C; Fiorino, C; Maggiulli, E; Alongi, F; Cattaneo, Gm; Di Muzio, N; Calandrino, R.
A multicenter LArge retrospectIve daTabase on the personalization of stereotactic ABlative radiotherapy use in lung metastases from colon-rectal cancer: The LaIT-SABR study
2022-01-01 Nicosia, L.; Franceschini, D.; Perrone-Congedi, F.; Casamassima, F.; Gerardi, M. A.; Rigo, M.; Mazzola, R.; Perna, M.; Scotti, V.; Fodor, A.; Iurato, A.; Pasqualetti, F.; Gadducci, G.; Chiesa, S.; Niespolo, R. M.; Bruni, A.; Alicino, G.; Frassinelli, L.; Borghetti, P.; Di Marzo, A.; Ravasio, A.; De Bari, B.; Sepulcri, M.; Aiello, D.; Mortellaro, G.; Sangalli, C.; Franceschini, M.; Montesi, G.; Aquilanti, F. M.; Lunardi, G.; Valdagni, R.; Fazio, I.; Scarzello, G.; Corti, L.; Vavassori, V.; Maranzano, E.; Magrini, S. M.; Arcangeli, S.; Gambacorta, M. A.; Valentini, V.; Paiar, F.; Ramella, S.; Di Muzio, N. G.; Livi, L.; Jereczek-Fossa, B. A.; Osti, M. F.; Scorsetti, M.; Alongi, F.
Outcome of adjuvant hypofractionated radiotherapy concomitant to chemotherapy in bile duct carcinoma
2021-01-01 Slim, N; Pacifico, P; Passoni, P; Tummineri, R; Ronzoni, M; Pedica, F; Fiorino, C; Deli, Am; Gardini, Ac; Cascinu, S; De Cobelli, F; Aldrighetti, L; DI MUZIO, NADIA GISELLA
PET in radiotherapy planning: Particularly exquisite test or pending and experimental tool?
2010-01-01 Gregoire, V; Chiti, A
PET/CT guided helical tomotherapy in patients with locally advanced pancreatic cancer
2005-01-01 Di Muzio, N; Broggi, S; Passoni, P; Schipani, S; Molinelli, S; Picchio, M; Calandrino, R; Fazio, F.
PET/CT with [18F]FDG to evaluate the response to helical tomotherapy in NSCLC and lung metastases
2006-01-01 Giovacchini, G; Di Muzio, N; Cattaneo, G; Messa, C; Mangili, P; Alongi, F; Picchio, M; Landoni, C; Calandrino, R; Fazio, F.
Post-operative Intensity-Modulated hypofractionated Image-Guided Radiotherapy in cholangiocarcinoma
2017-01-01 Slim, N; Chiorda, Bn; Gumina, C; Cattaneo, Gm; Reni, M; Aldrighetti, L; Deli, Am; Zerbetto, F; Passoni, P; Di Muzio, N
Predicting pathological response after radio-chemotherapy for rectal cancer: Impact of late oxaliplatin administration
2020-01-01 Broggi, S.; Passoni, P.; Gumina, C.; Palmisano, A.; Bresolin, A.; Burgio, V.; Di Chiara, A.; Elmore, U.; Mori, M.; Slim, N.; Ronzoni, M.; Rosati, R.; De Cobelli, F.; Di Muzio, N. G.; Fiorino, C.
Predictors of acute bowel toxicity in patients treated with IMRT whole pelvis irradiation after prostatectomy
2010-01-01 Perna, L; Alongi, F; Fiorino, C; Broggi, S; Cattaneo Giovanni, M; Cozzarini, C; Di Muzio, N; Calandrino, R
Radiomics signature as predictors of survival and local control after pancreatic carcinoma SBRT
2019-01-01 Cozzi, L; Comito, T; Fogliata, A; Franzese, C; Franceschini, D; Bonifacio, C; Tozzi, A; Di Brina, L; Clerici, E; Tomatis, S; Reggiori, G; Lobefalo, F; Stravato, A; Mancosu, P; Zerbi, A; Sollini, M; Margarita, K; Chiti, A; Scorsetti, M
Random forest analysis to predict Disease-Free Survival using FDG-PET and CT in Lung Cancer
2018-01-01 Kirienko, M; Lozza, L; Cozzi, L; Gennaro, N; Rossi, A; Voulaz, E; Chiti, A; Sollini, M
Results of hypofractionated stereotactic re-irradiation on 13 locally recurrent nasopharyngeal carcinomas
1999-01-01 Orecchia, R; Redda, Mgr; Ragona, R; Nassisi, D; Jereczek Fossa, B; Zurrida, S; Bussi, Mario; Succo, G; Sannazzari, G.
Role of PET/CT in monitoring patients during RT treatment for lung cancer
2005-01-01 Picchio, M; Soma, L; Schipani, S; Di Muzio, N; Dell'Oca, I; Tagliabue, M; Pajoro, U; Messa, C; Gilardi, Mc; Fazio, F.
Titolo | Data di pubblicazione | Autore(i) | File |
---|---|---|---|
Impact of 4DCT target definition on 3DCRT and IMRT planning of locally advanced pancreatic carcinoma | 1-gen-2007 | Sangalli, G; Passoni, P; Cattaneo, Gm; Broggi, S; Esposito, D; Bettinardi, V; Reni, M; Danna, M; Mancosu, P; Fazio, F; Calandrino, R | |
IMRT significantly reduces acute toxicity of whole-pelvis irradiation in patients treated with post-operative adjuvant or salvage radiotherapy after radical prostatectomy | 1-gen-2009 | Alongi, F; Fiorino, C; Cozzarini, C; Broggi, S; Perna, L; Cattaneo, Gm; Calandrino, R; Di Muzio, N | |
In reply to Fiorino et al.: The central role of the radiation oncologist in the multidisciplinary & multiprofessional model of modern radiation therapy | 1-gen-2021 | Alongi, F.; Arcangeli, S.; Cuccia, F.; D'Angelillo, R. M.; Di Muzio, N. G.; Filippi, A. R.; Jereczek-Fossa, B. A.; Livi, L.; Pergolizzi, S.; Scorsetti, M.; Corvo, R.; Magrini, S. M. | |
In-gantry or remote patient positioning? Monte Carlo simulations for proton therapy centers of different sizes | 1-gen-2012 | Fava, G; Widesott, L; Fellin, F; Amichetti, M; Viesi, V; Lomax, Aj; Lederer, L; Hug, Eb; Fiorino, C; Salvadori, G; Di Muzio, N; Schwarz, M | |
Internal target volume defined by contrast-enhanced 4D-CT scan in unresectable pancreatic tumour: evaluation and reproducibility | 1-gen-2010 | Cattaneo, Gm; Passoni, P; Sangalli, G; Slim, N; Longobardi, B; Mancosu, P; Bettinardi, V; Di Muzio, N; Calandrino, R | |
Intra- and inter-observer variability in contouring prostate and seminal vesicles: implications for conformal treatment planning | 1-gen-1998 | Fiorino, C; Reni, M; Bolognesi, A; Cattaneo, Gm; Calandrino, R | |
Intra-operative radiotherapy (IORT) in pancreatic cancer: Joint analysis of the ISIORT-Europe experience | 1-gen-2009 | Valentini, V; Calvo, F; Reni, M; Krempien, R; Sedlmayer, F; Buchler, Mw; Di Carlo, V; Doglietto, Gb; Fastner, G; Garcia-Sabrido, Jl; Mattiucci, G; Morganti, Ag; Passoni, P; Roeder, F; D'Agostino, Gr | |
Modeling set-up error by daily MVCT for prostate adjuvant treatment delivered in 20 fractions: Implications for the assessment of the optimal correction strategies | 1-gen-2009 | Broggi, S; Cozzarini, C; Fiorino, C; Maggiulli, E; Alongi, F; Cattaneo, Gm; Di Muzio, N; Calandrino, R. | |
A multicenter LArge retrospectIve daTabase on the personalization of stereotactic ABlative radiotherapy use in lung metastases from colon-rectal cancer: The LaIT-SABR study | 1-gen-2022 | Nicosia, L.; Franceschini, D.; Perrone-Congedi, F.; Casamassima, F.; Gerardi, M. A.; Rigo, M.; Mazzola, R.; Perna, M.; Scotti, V.; Fodor, A.; Iurato, A.; Pasqualetti, F.; Gadducci, G.; Chiesa, S.; Niespolo, R. M.; Bruni, A.; Alicino, G.; Frassinelli, L.; Borghetti, P.; Di Marzo, A.; Ravasio, A.; De Bari, B.; Sepulcri, M.; Aiello, D.; Mortellaro, G.; Sangalli, C.; Franceschini, M.; Montesi, G.; Aquilanti, F. M.; Lunardi, G.; Valdagni, R.; Fazio, I.; Scarzello, G.; Corti, L.; Vavassori, V.; Maranzano, E.; Magrini, S. M.; Arcangeli, S.; Gambacorta, M. A.; Valentini, V.; Paiar, F.; Ramella, S.; Di Muzio, N. G.; Livi, L.; Jereczek-Fossa, B. A.; Osti, M. F.; Scorsetti, M.; Alongi, F. | |
Outcome of adjuvant hypofractionated radiotherapy concomitant to chemotherapy in bile duct carcinoma | 1-gen-2021 | Slim, N; Pacifico, P; Passoni, P; Tummineri, R; Ronzoni, M; Pedica, F; Fiorino, C; Deli, Am; Gardini, Ac; Cascinu, S; De Cobelli, F; Aldrighetti, L; DI MUZIO, NADIA GISELLA | |
PET in radiotherapy planning: Particularly exquisite test or pending and experimental tool? | 1-gen-2010 | Gregoire, V; Chiti, A | |
PET/CT guided helical tomotherapy in patients with locally advanced pancreatic cancer | 1-gen-2005 | Di Muzio, N; Broggi, S; Passoni, P; Schipani, S; Molinelli, S; Picchio, M; Calandrino, R; Fazio, F. | |
PET/CT with [18F]FDG to evaluate the response to helical tomotherapy in NSCLC and lung metastases | 1-gen-2006 | Giovacchini, G; Di Muzio, N; Cattaneo, G; Messa, C; Mangili, P; Alongi, F; Picchio, M; Landoni, C; Calandrino, R; Fazio, F. | |
Post-operative Intensity-Modulated hypofractionated Image-Guided Radiotherapy in cholangiocarcinoma | 1-gen-2017 | Slim, N; Chiorda, Bn; Gumina, C; Cattaneo, Gm; Reni, M; Aldrighetti, L; Deli, Am; Zerbetto, F; Passoni, P; Di Muzio, N | |
Predicting pathological response after radio-chemotherapy for rectal cancer: Impact of late oxaliplatin administration | 1-gen-2020 | Broggi, S.; Passoni, P.; Gumina, C.; Palmisano, A.; Bresolin, A.; Burgio, V.; Di Chiara, A.; Elmore, U.; Mori, M.; Slim, N.; Ronzoni, M.; Rosati, R.; De Cobelli, F.; Di Muzio, N. G.; Fiorino, C. | |
Predictors of acute bowel toxicity in patients treated with IMRT whole pelvis irradiation after prostatectomy | 1-gen-2010 | Perna, L; Alongi, F; Fiorino, C; Broggi, S; Cattaneo Giovanni, M; Cozzarini, C; Di Muzio, N; Calandrino, R | |
Radiomics signature as predictors of survival and local control after pancreatic carcinoma SBRT | 1-gen-2019 | Cozzi, L; Comito, T; Fogliata, A; Franzese, C; Franceschini, D; Bonifacio, C; Tozzi, A; Di Brina, L; Clerici, E; Tomatis, S; Reggiori, G; Lobefalo, F; Stravato, A; Mancosu, P; Zerbi, A; Sollini, M; Margarita, K; Chiti, A; Scorsetti, M | |
Random forest analysis to predict Disease-Free Survival using FDG-PET and CT in Lung Cancer | 1-gen-2018 | Kirienko, M; Lozza, L; Cozzi, L; Gennaro, N; Rossi, A; Voulaz, E; Chiti, A; Sollini, M | |
Results of hypofractionated stereotactic re-irradiation on 13 locally recurrent nasopharyngeal carcinomas | 1-gen-1999 | Orecchia, R; Redda, Mgr; Ragona, R; Nassisi, D; Jereczek Fossa, B; Zurrida, S; Bussi, Mario; Succo, G; Sannazzari, G. | |
Role of PET/CT in monitoring patients during RT treatment for lung cancer | 1-gen-2005 | Picchio, M; Soma, L; Schipani, S; Di Muzio, N; Dell'Oca, I; Tagliabue, M; Pajoro, U; Messa, C; Gilardi, Mc; Fazio, F. |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile